Health Care & Life Sciences » Biotechnology | BioStem Technologies Inc.

BioStem Technologies Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2016
2017
Net Income before Extraordinaries
3,962.70
4,813.90
Depreciation, Depletion & Amortization
162.50
186.00
Other Funds
196.00
26.30
Funds from Operations
2,340.70
2,400.60
Changes in Working Capital
646.50
754.10
Net Operating Cash Flow
1,694.20
1,646.40
Capital Expenditures
716.70
147.70
Sale of Fixed Assets & Businesses
95.70
14.90
Net Investing Cash Flow
621.00
132.80
Issuance/Reduction of Debt, Net
400.00
55.00
Net Financing Cash Flow
2,032.40
1,664.70
Net Change in Cash
282.90
114.70
Free Cash Flow
2,410.90
1,794.20
Change in Capital Stock
1,436.40
1,583.40
Exchange Rate Effect
0.00
0.10

About BioStem Technologies

View Profile
Address
4749 North East, 11th Avenue
Oakland Park Florida 33334
United States
Employees -
Website http://www.biostemtechnologies.com
Updated 07/08/2019
BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.